How often must stability samples be tested?
Stability testing & climatic zones · Testing frequency. Verbatim excerpts from each authority's document, with the section.
SFDA Saudi Food and Drug Authority
GCC Stability Guidelines v3.3 (2018) — archived copy
For products with a proposed shelf-life of at least 12 months, the frequency of testing at the long-term storage condition should normally be every three months over the first year, every six months over the second year and annually thereafter throughout the proposed shelf-life (e.g., 0, 3, 6, 9, 12, 18, 24, 36 months).GCC v3.3 (archived) · 3.2.5 Testing frequency ↗
At the accelerated storage condition, a minimum of three time points, including the initial and final time points (e.g. 0, 3 and 6 months), from a six-month study is recommended.GCC v3.3 (archived) · 3.2.5 Testing frequency ↗
EU European Union
ICH Q1A(R2) · EMA guidelines
For products with a proposed shelf life of at least 12 months, the frequency of testing at the long term storage condition should normally be every 3 months over the first year, every 6 months over the second year, and annually thereafter through the proposed shelf life.ICH Q1A(R2) · 2.2.6 Testing Frequency ↗
At the accelerated storage condition, a minimum of three time points, including the initial and final time points (e.g., 0, 3, and 6 months), from a 6-month study is recommended.ICH Q1A(R2) · 2.2.6 Testing Frequency ↗
US FDA US Food and Drug Administration
Q1A(R2) · Q1E · ANDA guidance
For products with a proposed shelf life of at least 12 months, the frequency of testing at the long-term storage condition should normally be every 3 months over the first year, every 6 months over the second year, and annually thereafter through the proposed shelf life.FDA Q1A(R2) · 2.2.6 ↗
At the accelerated storage condition, a minimum of three time points, including the initial and final time points (e.g., 0, 3, and 6 months), from a 6-month study is recommended.FDA Q1A(R2) · 2.2.6 ↗
When testing at the intermediate storage condition is called for as a result of significant change at the accelerated storage condition, a minimum of four time points, including the initial and final time points (e.g., 0, 6, 9, 12 months), from a 12-month study is recommended.FDA Q1A(R2) · 2.2.6 ↗
WHO World Health Organization
TRS 1010 Annex 10 · zone table
For products with a proposed shelf life of at least 12 months, the frequency of testing at the long-term storage condition should normally be every three months over the first year, every six months over the second year and annually thereafter throughout the proposed shelf life.WHO TRS 1010 Annex 10 · 2.2.6 Testing frequency ↗
At the accelerated storage condition, a minimum of three time points, including the initial and final time points (e.g. 0, 3 and 6 months), from a six-month study is recommended.WHO TRS 1010 Annex 10 · 2.2.6 Testing frequency ↗
When testing at the intermediate storage condition is called for as a result of significant change at the accelerated storage condition, a minimum of four time points, including the initial and final time points (e.g. 0, 6, 9 and 12 months), from a 12-month study is recommended.WHO TRS 1010 Annex 10 · 2.2.6 Testing frequency ↗
Other questions in Stability testing & climatic zones
- What is the long-term storage condition for stability studies?
- What is the accelerated storage condition for stability studies?
- When is an intermediate stability storage condition required?
- What stability data is required at submission for a product with a new active substance?
- What stability data is required at submission for a generic product?
- What stability data is required for the active substance (API)?
- What is a significant change for the finished product in stability testing?
- Can the shelf life be extrapolated beyond the real-time stability data?
- Which label storage statement corresponds to the tested storage condition?
- What post-approval stability commitments are required?
Excerpts are selected for comparison and are not the whole requirement; the binding text is each authority's current official document. Not regulatory advice.